10-Q: AquaBounty Technologies Reports Significant Losses and Asset Impairments in Q2 2024

AquaBounty Technologies reported a substantial net loss of $50.5 million for the second quarter of 2024, primarily due to asset impairments and reduced sales of GE Atlantic salmon.

Summary

• AquaBounty Technologies reported a net loss of $50.5 million for the three months ended June 30, 2024, and a net loss of $61.7 million for the six months ended June 30, 2024.
• The company experienced a significant decrease in product revenue, with a 77% decrease in the three-month period and a 45% decrease in the six-month period compared to the same periods in 2023.
• The decrease in revenue was primarily due to reduced sales of GE Atlantic salmon, partially offset by increased sales of conventional Atlantic salmon eggs and fry.
• A major factor contributing to the losses was a $44.5 million non-cash impairment charge in Q2 against long-lived assets related to the Indiana farm and certain Ohio farm equipment, and a total of $48.7 million for the six month period.
• The company sold its Indiana farm for net proceeds of $9.2 million on July 26, 2024, and repaid a $6.5 million loan from JMB Capital Partners Lending.
• AquaBounty is facing substantial doubt about its ability to continue as a going concern due to ongoing losses and the need for additional capital.
• The company is exploring various funding options, including the sale of non-core assets, debt financing, and strategic transactions.

Sentiment

Score: 2

Explanation: The document indicates significant financial distress, substantial losses, asset impairments, and uncertainty about the company's ability to continue as a going concern. The sentiment is very negative due to the severity of the financial challenges and the lack of a clear path to profitability.

Positives

• The sale of the Indiana farm generated $9.2 million in net proceeds, which was used to repay a $6.5 million loan.
• The company is actively pursuing various funding and strategic alternatives to address its financial challenges.
• Sales of conventional Atlantic salmon eggs and fry increased, partially offsetting the decline in GE Atlantic salmon sales.

Negatives

• The company experienced a substantial net loss of $50.5 million in Q2 2024 and $61.7 million for the six months ended June 30, 2024.
• Product revenue decreased significantly due to the winding down of operations at the Indiana farm and a halt in GE Atlantic salmon sales.
• A significant non-cash impairment charge of $44.5 million was recorded in Q2 2024.
• The company has only $728,000 in cash and cash equivalents as of June 30, 2024.
• There is substantial doubt about the company's ability to continue as a going concern.
• Construction activities at the Ohio farm have been paused due to funding issues.

Risks

• The company has a history of net losses and expects to incur future losses.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company's ability to raise additional capital is uncertain.
• The company is exposed to risks related to inflation, which is increasing operating and capital costs.
• The company faces risks related to the commercial acceptance of its genetically engineered salmon.
• The company is dependent on third parties for the processing, distribution, and sale of its products.
• The company is subject to risks related to disease outbreaks, fish mortality, and farm shutdowns.

Future Outlook

The company expects to continue to incur losses and requires additional financing to fund its operations and execute its business plan. They are exploring various funding options, including the sale of non-core assets, debt financing, and strategic transactions. The company plans to sell additional equipment assets from its Ohio farm to increase cash liquidity.

Management Comments

• We believe that we are a distinctive brand in the field of land-based aquaculture, leveraging decades of technology expertise to deliver innovative solutions that address food insecurity and climate change issues, while improving efficiency and sustainability.
• We are actively engaged in genetic, genomic, fish health and fish nutrition research, which drive continuous improvement in our operations and may lead to new, disruptive technologies and products that could further expand our competitive offerings.
• We expect inflation to continue to negatively impact our results of operations for the near-term.

Industry Context

The company operates in the land-based aquaculture industry, which is focused on sustainable and efficient fish farming. The company's challenges highlight the capital-intensive nature of this industry and the risks associated with scaling up production of genetically engineered products. The company's struggles also reflect broader industry trends of rising costs and the need for innovative financing solutions.

Comparison to Industry Standards

• Compared to traditional sea-cage farming, AquaBounty's land-based recirculating aquaculture system aims to reduce environmental impact and disease risk.
• However, the company's financial performance is significantly worse than many established aquaculture companies, which are typically profitable and have strong cash flows.
• Companies like Mowi and Grieg Seafood, which are major players in traditional salmon farming, have significantly higher revenues and profits.
• The company's struggles highlight the challenges of commercializing genetically engineered products, which face regulatory hurdles and consumer acceptance issues.
• The company's financial results are also worse than other land-based aquaculture companies such as Atlantic Sapphire, which has also faced significant challenges in scaling up production and achieving profitability.

Stakeholder Impact

• Shareholders are at risk of losing most or all of their investment if the company cannot continue as a going concern.
• Employees may face job insecurity due to the company's financial challenges.
• Customers may experience disruptions in product supply due to the company's operational issues.
• Suppliers and creditors may face increased risk of non-payment due to the company's financial difficulties.

Next Steps

• The company will continue to pursue funding sources, including the sale of non-core equipment assets from the Ohio farm.
• The company will explore debt financing secured by its unencumbered assets.
• The company will consider potential strategic transactions.
• The company will continue to monitor and manage its cash flow and operating expenses.

Key Dates

Keywords

AquaBounty, genetically engineered salmon, AquAdvantage salmon, aquaculture, farm, net loss, asset impairment, going concern, financing, recirculating aquaculture system